Izumi Kawachi

Has grant

Associate Professor

Niigata University
Country flagJapan

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Izumi Kawachi is an Associate Professor at Niigata University, Japan. His research primarily focuses on neuromyelitis optica spectrum disorder (NMOSD), innate immunology, and related conditions, evidenced by his recent articles on the safety and effectiveness of Satralizumab and clinical outcomes in various neurological disorders. Dr. Kawachi's work contributes significantly to understanding the clinical profiles and long-term outcomes of conditions such as anti-AMPA receptor encephalitis and IgG4-related disease.

Recent Grants

Grant: Close

自己免疫性グリア病における免疫細胞由来「細胞外DNAトラップ」の生物学的意義の解明

Open Date: 2023-04-01

Close Date: 2026-03-31

Grant: Close

細胞外小胞の臓器特異性に着目した視神経脊髄炎関連疾患の再発予測の確立

Open Date: 2021-04-01

Close Date: 2024-03-31

Grant: Close

神経免疫疾患のエビデンスに基づく診断基準・重症度分類・ガイドラインの妥当性と患者QOLの検証

Open Date: 2020-04-01

Close Date: 2022-03-31

Grant: Close

神経免疫疾患のエビデンスに基づく診断基準・重症度分類・ガイドラインの妥当性と患者QOLの検証

Open Date: 2020-04-01

Close Date: 2022-03-31

Grant: Close

神経免疫疾患のエビデンスに基づく診断基準・重症度分類・ガイドラインの妥当性と患者QOLの検証

Open Date: 2020-04-01

Close Date: 2022-03-31

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Collaborators (6)

Norihiro Harada

Juntendo University Graduate School of Medicine

JAPAN
View details

Sam Hooshmand

Medical College of Wisconsin

UNITED STATES
View details

Satoshi Ueki

Lecturer

Niigata University

JAPAN
View details

Yuji Yamamoto

Osaka University Graduate School of Medicine

JAPAN
View details

Etsuji SAJI

Niigata University

JAPAN
View details

norio chihara

Project Associate Professor

Kobe University Hospital

JAPAN
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.